Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of vaginal vs intravenous oxytocin in postmenopausal women with vaginal atrophy
2013-002690-22Phase 3Completed
- Sponsor
- Peptonic Medical
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of vagitocin in vaginal atrophy (2 arms), sponsored by Peptonic Medical. Primary endpoint: Oxytocin plasma levels and pharmacokinetic parameters after intravaginal and intravenous administration. Started Jun 2013; status: completed.
02
Drugs
vagitocin
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on 2013-002690-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002690-22.